Mark Hasleton

Mark Hasleton

Directeur Général chez
ProTA Therapeutics Pty Ltd.
54 ans
Health Technology
Consumer Services

Profil

Mark Hasleton currently works at Prota Therapeutics Pty Ltd., as Chief Executive Officer.
Dr. Hasleton also formerly worked at Teva Pharmaceutical Industries Ltd., as Senior Director-Global New Therapeutic Entities from 2010 to 2018, Bristol Myers Squibb Co., as Manager-EMEA Business Operations, and Oramed Pharmaceuticals, Inc., as Vice President-Business Development from 2018 to 2019.
Dr. Hasleton received his doctorate degree from Imperial College London, graduate degree from The University of Manchester, and Masters Business Admin degree from Imperial College Business School.

Postes actifs de Mark Hasleton

SociétésPosteDébut
Directeur Général -

Anciens postes connus de Mark Hasleton

SociétésPosteFin
ORAMED PHARMACEUTICALS INC. Corporate Officer/Principal 27/08/2019
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Corporate Officer/Principal 01/01/2018
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
Voir l'expérience en détail de Mark Hasleton

Formation de Mark Hasleton

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

78

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Mark Hasleton
🔇